ngsmam | 1024
NGS Breast Carcinoma BRCAness
Keywords:
AKT1
ATM
BARD1
BRCA1
BRCA2
BRIP1
Breast Cancer
CDK12
CHEK2
ERBB2
ESR1
FANCD2
HER2
HRR
MRE11
Mammary Gland
NBN
Next Generation Sequencing
PALB2
PIK3CA
PTEN
RAD51B
TP53
Status
| Material |
|
||
|---|---|---|---|
| Hint |
Whole Sequencing: BRCA1, BRCA2, ATM, BARD1, BRIP1, CDK12, CHEK2, FANCD2, HER2, MRE11, NBN, PALB2, RAD51B, TP53; Variants Hotspot: ERBB2 (=HER2), ESR1, PIK3CA, PTEN, AKT1. To order this analysis, please contact the Customer Service Center: contact@viollier.ch or 0848 121 121.This analysis may result in excess information. This will be communicated, unless it is noted otherwise when placing the order. Since in rare cases there may also be indications of hereditary changes, the GUMG shall ensure the patient is informed accordingly (see www.viollier.ch/en/SGMG_consent). Tarification: according to Tarmed. |
||
| Duration | 5 days | ||
| Frequency | 2 x per week | ||
| Method | Next Generation Sequencing |
Price/Rate
| Price |
Price
CHF 0.00
|
|---|---|
| Rate |
Rate
0.00 TP
|